Observational study of lipid profile and LDL particle size in patients with metabolic syndrome

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Sancho Rodríguez, Natalia ^a   Avilés Plaza, Francisco V ^a   Granero Fernández, Esteban ^b   Hernández Martínez, Antonio M ^a   Albaladejo Otán, María ^c   Martínez Mernández, Pedro ^a   Parra Pallarés, Soledad ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b Health Service   (Spain)

^c University Hospital Santa Lucia   (Spain)

Author keywords

Atherosclerosis; LDLC particle size; Metabolic Syndrome

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPID;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CENTER; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBSERVATIONAL STUDY; PARTICLE SIZE; PHENOTYPE; PRIMARY MEDICAL CARE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; MIDDLE AGED; MORPHOMETRICS; PATHOPHYSIOLOGY; RISK FACTOR; SEXUAL DEVELOPMENT; SPAIN;

ADULT; AGED; BIOLOGICAL MARKERS; BODY WEIGHTS AND MEASURES; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; LIPIDS; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PARTICLE SIZE; RISK FACTORS; SEX CHARACTERISTICS; SPAIN; TRIGLYCERIDES;

EID: 80053172647     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-162     Document Type: Article

References (29)

1. The global burden of chronic diseases: overcoming impediments to prevention and control. Yach D, Hawkes C, Gould CL, Hofman KJ, JAMA 2004 291 21 2616 22 10.1001/jama.291.21.2616 15173153 (Pubitemid 38702780)
2. Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study. Lorenzo C, Williams K, Hunt KJ, Haffner SM, Diabetes Care 2006 29 3 625 30 10.2337/diacare.29.03.06.dc05-1755 16505517 (Pubitemid 44115364)
3. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 25 3143 421 12485966
4. Small LDLC, atherogenic dyslipidemia, and the metabolic syndrome. Grundy SM, Circulation 1997 95 1 1 4 8994405 (Pubitemid 27029931)
5. Metabolic origins and clinical significance of LDLC heterogeneity. Berneis KK, Krauss RM, J Lipid Res 2002 43 9 1363 79 10.1194/jlr.R200004-JLR200 12235168
6. Modificaciones cualitativas de las lipoproteínas. Implicaciones fisiopatolágicas. Parra Pallarés S, Albaladejo Otán MD, Martínez Hernández P, An Med Interna 2000 17 317 23
7. Small LDLC-cholesterol is superior to LDLC-cholesterol for determining severe coronary atherosclerosis. Koba S, Yokota Y, Hirano T, Ito Y, Ban Y, Tsunoda F, J Atheroscler Thromb 2008 15 5 250 60 10.5551/jat.E572 18981650
8. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Austin MA, Brunzell JD, Fitch WL, Krauss RM, Arteriosclerosis 1990 10 4 520 30 10.1161/01.ATV.10.4.520 2369363 (Pubitemid 20220574)
9. Lipid and lipoprotein factors associated with variation in Lp(a) density. Rainwater DL, Ludwig MJ, Haffner SM, VandeBerg JL, Arterioscler Thromb Vasc Biol 1995 15 3 313 9 10.1161/01.ATV.15.3.313 7749840
10. Particle size: the key to the atherogenic lipoprotein? Rajman I, Maxwell S, Cramb R, Kendall M, QJM 1994 87 12 709 20 7859047
11. Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction? Jungner I, Sniderman AD, Furberg C, Aastveit AH, Holme I, Walldius G, Am J Cardiol 2006 97 7 943 6 10.1016/j.amjcard.2005.10.062 16563891
12. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). De BG, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Eur J Cardiovasc Prev Rehabil 2003 10 4 1 S10 10.1097/00149831-200308000-00004 14555889
13. The National Cholesterol Education Program Adult Treatment Panel III guidelines. Lipsy RJ, J Manag Care Pharm 2003 9 1 Suppl 2 5 14613464
14. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 6 499 502 4337382
15. Low density lipoprotein particle diameter in young, nonobese, normolipidemic Japanese men. Kazumi T, Kawaguchi A, Hozumi T, Nagao M, Iwahashi M, Hayakawa M, Atherosclerosis 1999 142 1 113 9 10.1016/S0021-9150(98)00201-9 9920512 (Pubitemid 28551816)
16. Evaluacián de un método electroforético para el subfraccionamiento de las partículas plasmáticas de lipoproteínas de baja densidad. Luna Juan Gabriel Calle, García Miguel Boronat, Otán María Dolores Albaladejo, Fernández Esteban Granero, Martínez Antonio Miguel Hernández, Pallarés Soledad Parra, Rev Lab Clin 2010 3 1 31 6
17. Gender differences among middle-aged Koreans for health-related quality of life related to metabolic syndrome. Sohn YJ, Sohn HS, Kwon JW, Qual Life Res 2010
18. Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance. Julius U, Dittrich M, Pietzsch J, Int J Clin Pract 2007 61 11 1798 804 10.1111/j.1742-1241.2007.01507.x 17935544 (Pubitemid 47573085)
19. Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Austin MA, Hokanson JE, Brunzell JD, Curr Opin Lipidol 1994 5 6 395 403 10.1097/00041433-199412000-00002 7712044
20. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDLC) subfractions: relative contribution of small, dense LDLC to coronary heart disease risk. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Atherosclerosis 1994 106 2 241 53 10.1016/0021-9150(94)90129-5 8060384 (Pubitemid 24188766)
21. Low-density lipoprotein size, pravastatin treatment, and coronary events. Campos H, Moye LA, Glasser SP, Stampfer MJ, Sacks FM, JAMA 2001 286 12 1468 74 10.1001/jama.286.12.1468 11572739 (Pubitemid 33015503)
22. Usefulness of serum total cholesterol/triglyceride ratio for predicting the presence of small, dense LDLC. Yoshida A, Kouwaki M, Matsutani Y, Fukuchi Y, Naito M, J Atheroscler Thromb 2004 11 4 215 9 10.5551/jat.11.215 15356381
23. Assessment of the validity of the frequently used lipid indices for predicting LDLC peak particle diameter in a large cohort of 1955 normal and dyslipidemic subjects. Decary S, Dumont G, Lamarche B, Hogue JC, Tremblay AJ, Bergeron J, Clin Biochem 2010 43 4-5 401 6 10.1016/j.clinbiochem.2009.11.010 19944087
24. Should we measure routinely the LDLC peak particle size? Rizzo M, Berneis K, Int J Cardiol 2006 107 2 166 70 10.1016/j.ijcard.2005.02.035 16412793
25. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, JAMA 1996 276 11 882 8 10.1001/jama.276.11. 882 8782637 (Pubitemid 26301607)
26. Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes. Austin MA, Edwards KL, Curr Opin Lipidol 1996 7 3 167 71 10.1097/00041433-199606000-00010 8818515 (Pubitemid 26234230)
27. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Talmud PJ, Hawe E, Miller GJ, Humphries SE, Arterioscler Thromb Vasc Biol 2002 22 11 1918 23 10.1161/01.ATV.0000035521.22199.C7 12426225 (Pubitemid 35315782)
28. Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk. Sniderman AD, St-Pierre AC, Cantin B, Dagenais GR, Despres JP, Lamarche B, Am J Cardiol 2003 91 10 1173 7 10.1016/S0002-9149(03)00262-5 12745098 (Pubitemid 36561379)
29. Changes in plasma triglyceride levels shift lipoprotein(a) density in parallel with that of LDLC independently of apolipoprotein(a) size. Nakajima K, Hinman J, Pfaffinger D, Edelstein C, Scanu AM, Arterioscler Thromb Vasc Biol 2001 21 7 1238 43 10.1161/hq0701.092246 11451758 (Pubitemid 34215157)